154 related articles for article (PubMed ID: 8268438)
1. Role of ischemia-reperfusion on myocardial cyclic AMP and cyclic AMP phosphodiesterase: effects of amrinone on regional myocardial force and shortening.
Tse J; Cimini C; Kedem J; Rodriquez E; Gonzalez M; Weiss HR
J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):566-72. PubMed ID: 8268438
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracoronary infusions of amrinone and dobutamine on segment shortening, blood flow, and oxygen consumption in in situ canine hearts.
Crystal GJ; Rock MH; Kim SJ; Salem MR
Anesth Analg; 1994 Dec; 79(6):1066-74. PubMed ID: 7978428
[TBL] [Abstract][Full Text] [Related]
3. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
4. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
6. Myocardial cyclic AMP augmentation with high-dose PDEIII inhibitor in terminal warm blood cardioplegia.
Ko Y; Morita K; Nagahori R; Kinouchi K; Shinohara G; Kagawa H; Hashimoto K
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):311-7. PubMed ID: 19901885
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic stimulation of reperfused myocardium after 2-hour ischemia.
LaBruno S; Naim KL; Li JK; Drzewiecki G; Kedem J
J Cardiovasc Pharmacol; 1998 Oct; 32(4):535-42. PubMed ID: 9781921
[TBL] [Abstract][Full Text] [Related]
8. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals.
Przyklenk K
Circulation; 1994 Mar; 89(3):1272-81. PubMed ID: 8124816
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
[TBL] [Abstract][Full Text] [Related]
10. Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion.
Nichols WW; Nicolini FA; Yang BC; Henson K; Stechmiller JK; Mehta JL
Am Heart J; 1994 May; 127(5):1201-11. PubMed ID: 8172047
[TBL] [Abstract][Full Text] [Related]
11. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
Pagel PS; Hettrick DA; Warltier DC
Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
Lochner A; Genade S; Tromp E; Opie L; Moolman J; Thomas S; Podzuweit T
Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
[TBL] [Abstract][Full Text] [Related]
13. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
14. The effects of isoflurane on regional myocardial contractility and metabolism in "stunned" myocardium in acutely instrumented dogs.
Kanaya N; Fujita S
Anesth Analg; 1994 Sep; 79(3):447-54. PubMed ID: 8067547
[TBL] [Abstract][Full Text] [Related]
15. Effect of combining phosphodiesterase III inhibitors with St Thomas Hospital's solution used as transplantation preservative solution in isolated rat hearts.
Besirli K; Burhani SM; Arslan C; Suzer O; Sayin AG
Transplant Proc; 2006 Jun; 38(5):1253-8. PubMed ID: 16797275
[TBL] [Abstract][Full Text] [Related]
16. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
Abe Y; Kitada Y; Narimatsu A
J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
[TBL] [Abstract][Full Text] [Related]
17. The cardiotonic agent amrinone does not increase anatomic infarct size.
Campbell CA; Mehta PM; Wynne J; Kloner RA
J Cardiovasc Pharmacol; 1987 Feb; 9(2):225-9. PubMed ID: 2436003
[TBL] [Abstract][Full Text] [Related]
18. Early administration of amrinone does not impair regional metabolism of O2 or lactate and, by improving myocardial performance, preserves myocardial blood flow in the ischemic canine heart.
Sidi A; Pool JM; Rush W
Anesth Analg; 1993 Jun; 76(6):1201-12. PubMed ID: 8498655
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in postischemic recovery in the stunned canine myocardium.
Farber NE; Pieper GM; Gross GJ
Am Heart J; 1987 Nov; 114(5):1086-95. PubMed ID: 3673875
[TBL] [Abstract][Full Text] [Related]
20. Effect of isoproterenol on coronary blood flow and signal transduction responses in thyroxine-treated rabbit hearts.
Rodriguez E; Weiss HR; Gonzalez M; Tse J
J Mol Cell Cardiol; 1993 Aug; 25(8):939-47. PubMed ID: 8263963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
